Response to empirical anti-tuberculosis treatment in patients with sputum smear-negative pulmonary tuberculosis Source: Eur Respir J 2006; 28: Suppl. 50, 845s Year: 2006
Delays in diagnosis and treatment of patients with smear-positive pulmonary tuberculosis Source: Eur Respir J 2005; 26: Suppl. 49, 689s Year: 2005
Development of mycobacterium tuberculosis additional drug resistance during chemotherapy of disseminated pulmonary tuberculosis Source: Eur Respir J 2007; 30: Suppl. 51, 663s Year: 2007
Treatment results of new cases of sputum-positive pulmonary tuberculosis with standard chemotherapeutical regimen Source: Eur Respir J 2002; 20: Suppl. 38, 367s Year: 2002
A review of the diagnosis and treatment of smear-negative pulmonary tuberculosis Source: Annual Congress 2008 - Problems in managing pulmonary and extrapulmonary tuberculosis Year: 2008
A T-cell-based assay for rapid diagnosis of difficult cases of tuberculosis (TB): smear negative pulmonary and extra-pulmonary TB Source: Eur Respir J 2005; 26: Suppl. 49, 240s Year: 2005
Efficacy of standard chemotherapy regimen in patients with newly detected sputum-positive destructive pulmonary tuberculosis Source: Eur Respir J 2003; 22: Suppl. 45, 40s Year: 2003
Diaskintest at patients after successful treatment of lung tuberculosis Source: International Congress 2017 – Migrants and screening Year: 2017
Effectiveness of chemotherapy in newly detected patients with pulmonary tuberculosis with poly-resistance Source: Annual Congress 2010 - Tuberculosis drug resistance Year: 2010
Characteristics of smear-positive pulmonary tuberculosis patients with delayed diagnosis Source: Virtual Congress 2020 – Non-tuberculous mycobacteria and latent tuberculosis infection Year: 2020
Local artificial atelectasis in treatment of end-stage XDR cavitary tuberculosis Source: Annual Congress 2009 - Multi/extensively-drug resistant tuberculosis Year: 2009
Efficiency of standard chemotherapy of patients with pulmonary TB with relapses and treatment failure at drug resistance of M. tuberculosis Source: Eur Respir J 2001; 18: Suppl. 33, 339s Year: 2001
Crohn‘s disease or extrapulmonary tuberculosis? Source: Annual Congress 2009 - Extrapulmonary tuberculosis and non-tuberculous-mycobacteria (NTM) infections Year: 2009
The staged cavernomyoplasty at the patients with the progressing destructive tuberculosis of a single lung Source: Eur Respir J 2007; 30: Suppl. 51, 421s Year: 2007
The coexistance of active pulmonary tuberculosis in lung cancer patients Source: Annual Congress 2007 - Epidemiology of tuberculosis II Year: 2007
A randomized study of the bronchoscopic valve blockade of the affected part of the lung in the complex treatment of patients with cavitary drug-resistant pulmonary tuberculosis with treatment failure Source: Annual Congress 2013 –Tuberculosis: epidemiology and public health management II Year: 2013
Farmer‘s lung or miliary tuberculosis? Source: Eur Respir J 2005; 26: Suppl. 49, 600s Year: 2005
The evaluation of the relapse or treatment interrupted pulmonary tuberculosis cases Source: Eur Respir J 2006; 28: Suppl. 50, 21s Year: 2006
The profile of patients with pulmonary and extrapulmonary tuberculosis Source: Eur Respir J 2001; 18: Suppl. 33, 312s Year: 2001
Time course of sputum positivity during chemotherapy in smear-positive pumonary tuberculosis Source: Eur Respir J 2001; 18: Suppl. 33, 339s Year: 2001